bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.08.07.669054

Sex-Specific Metabolic Programming in Human Neutrophil Subsets

Abstract

BackgroundSex differences in immune responses are well-documented, with females exhibiting more robust immunity against infections but higher susceptibility to autoimmune diseases, while males often demonstrate more severe inflammatory pathology. Neutrophils which are key players in the innate immune response, display sex-based functional differences, but whether these extend to metabolic programming, particularly in low-density neutrophils (LDNs), remains unknown. MethodsWe isolated LDNs and normal-density neutrophils (NDNs) from healthy human donors using density gradient centrifugation and negative selection. Cellular metabolism was assessed via Seahorse XF analysis (measuring oxygen consumption rate, OCR, and extracellular acidification rate, ECAR), alongside flow cytometry for maturity markers (CD16hi/lo). ResultsMale LDNs exhibited significantly higher basal OCR and ATP production than female LDNs, while no sex differences were observed in NDNs. Strikingly, male LDNs had higher OCR and glycolysis than their matched NDNs, whereas female NDNs were more oxidative than their LDNs. These metabolic differences were independent of neutrophil maturity, as CD16hi frequencies did not differ between subsets or sexes. ConclusionsOur study reveals, for the first time, subset-specific sexual dimorphism in neutrophil metabolism whereby male LDNs adopt a hypermetabolic (oxidative/glycolytic) phenotype, while female NDNs retain higher oxidative capacity. This reprogramming occurs independently of developmental stage, suggesting sex hormones or epigenetic regulation may drive these differences. These findings provide a metabolic basis for sex-biased immune responses and highlight the need for sex-stratified approaches in neutrophil-targeted therapies. Plain English SummaryMen and women fight infections differently, and our study could reveal why--their immune cells produce energy in distinct ways. We examined two types of neutrophils (infection-fighting cells), normal cells (NDNs) and low-density cells (LDNs) found in inflammation. Using advanced metabolic measurements, we discovered that mens LDNs use more oxygen and generate more energy than womens. Surprisingly, while mens LDNs were more active than their normal neutrophils, women showed the opposite--their normal neutrophils were more energetic than their LDNs. These differences werent due to cell maturity, suggesting biological distinctions between sexes. This may help explain why men often have worse outcomes in diseases like sepsis (where oxygen-driven inflammation dominates), while women are more prone to autoimmune diseases like lupus. Our findings could lead to better sex-specific treatments by dampening overactive immune responses in men or adjusting metabolism in women to prevent autoimmune flares. This research highlights why medical studies must consider sex differences, as one-size-fits-all treatments may miss key biological variations. HighlightsO_LICD16hi frequencies show no sex differences, however female (but not male) NDNs contain significantly more mature CD15+ CD16hi cells than their LDNs, revealing female-specific maturation differences between subsets. C_LIO_LIFirst report of sex-specific metabolic differences in LDNs where males exhibit significantly higher basal respiration and ATP production than female LDNs. C_LIO_LIMale LDNs show higher OCR than matched NDNs, while female NDNs are more oxidative than their LDNs. C_LI

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yennemadi, A. S., Murphy, F. K., Keane, J., Leisching, G.. 2025-08-10. Sex-Specific Metabolic Programming in Human Neutrophil Subsets. https://doi.org/10.1101/2025.08.07.669054

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ksp37 is a rapidly mobilized NK cell secretory protein that engages FGF2

A key feature of natural killer (NK) cells is their preloaded arsenal of effector molecules, allowing them to rapidly respond upon activation. In this study, we characterized a previously unexplored secretory protein, termed killer-specific secretory protein of 37 kDa (Ksp37), which is highly abundant in differentiated CD56dim NK cells. Ksp37 is rapidly secreted in a dose-dependent and JAK-1 dependent manner upon low levels of cytokine stimulation, making it a sensitive readout for NK cell activation. Following secretion, intracellular levels were rapidly replenished, preserving responsiveness to subsequent cytokine stimulation. We found that Ksp37 is stored in polarized intracellular compartments distinct from those containing canonical cytotoxic effector molecules, including granzyme B and perforin, which require stronger stimulation for release. Lastly, we identified Ksp37 as a novel binding partner of fibroblast growth factor 2 (FGF2). This opens new avenues of exploration for the role of NK cells in remodeling their extracellular environment by modulating the FGF2-FGFR1 axis, which plays a key role in tumor growth, angiogenesis and tissue repair.

immunology↗

ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections

Severe neutropenia predisposes patients to life-threatening infections, while donor-dependent granulocyte transfusions are limited by availability and variable cell quality. Here, we engineered human induced pluripotent stem cells (iPSCs) to constitutively or inducibly express angiotensin-converting enzyme (ACE) and differentiated them into functional ACE-engineered neutrophils (ACE-iNeu). ACE expression enhanced granulocytic maturation, reactive oxygen species generation, inflammatory cytokine production, and antimicrobial signaling. ACE-iNeu exhibited enhanced bactericidal activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Following adoptive transfer into neutropenic mice, ACE-iNeu significantly reduced circulating and tissue bacterial burdens. Integrated metabolomic and transcriptomic analyses revealed ACE-associated alterations in adenine nucleotide abundance and developmental and inflammatory pathways. Together, these findings establish ACE engineering as a strategy to enhance the production and antimicrobial function of human iPSC-derived neutrophils and support further preclinical development of engineered granulocyte therapies for severe drug-resistant infections.

immunology↗

Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

immunology↗